These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 9808093
21. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS. Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561 [Abstract] [Full Text] [Related]
22. Impact of recipient ACE I/D genotype on kidney function in renal transplant patients: a meta-analysis of cross-sectional and longitudinal studies. Cargnin S, Quaglia M, Canonico PL, Stratta P, Terrazzino S. Pharmacogenomics; 2015 Nov; 16(16):1887-902. PubMed ID: 26555566 [Abstract] [Full Text] [Related]
24. Assessment of the relationship between ACE I/D gene polymorphism and renal allograft survival. Yang CH, Lu Y, Chen XX, Xian WF, Tu WF, Li HY. J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):813-9. PubMed ID: 25784711 [Abstract] [Full Text] [Related]
27. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E. J Am Soc Nephrol; 1995 Dec; 6(6):1676-8. PubMed ID: 8749698 [Abstract] [Full Text] [Related]
30. Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism. Nonoguchi H, Kiyama S, Inoue H, Nakayama Y, Inoue T, Kohda Y, Machida K, Tajima A, Kitamura K, Miyoshi T, Shimada H, Shimada H, Tajiri M, Honda Y, Tanaka M, Tomita K. Clin Nephrol; 2003 Oct; 60(4):225-32. PubMed ID: 14579936 [Abstract] [Full Text] [Related]
31. Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Fernández-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L. Kidney Int; 1998 Jun; 53(6):1743-7. PubMed ID: 9607207 [Abstract] [Full Text] [Related]
32. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism. Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, Kingma JH, Witteman JC, Stricker BH. Pharmacogenet Genomics; 2005 Feb; 15(2):75-81. PubMed ID: 15861031 [Abstract] [Full Text] [Related]
35. Increased immunogenicity and cause of graft loss of old donor kidneys. Fijter JW, Mallat MJK, Doxiadis IIN, Ringers J, Rosendaal FR, Claas FHJ, Paul LC. J Am Soc Nephrol; 2001 Jul; 12(7):1538-1546. PubMed ID: 11423584 [Abstract] [Full Text] [Related]
36. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M. J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802 [Abstract] [Full Text] [Related]
37. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population. Jalil JE, Piddo AM, Cordova S, Chamorro G, Braun S, Jalil R, Vega J, Jadue'P L, Lavandero S, Lastra P. Am J Hypertens; 1999 Jul; 12(7):697-704. PubMed ID: 10411367 [Abstract] [Full Text] [Related]
38. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, Saga D, Kondo D, Akazawa K, Sakatsume M, Gejyo F. Hypertension; 2003 Sep; 42(3):304-9. PubMed ID: 12885793 [Abstract] [Full Text] [Related]